Boston Scientific forward PE BSX

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Oct 23, 2026: 14.1×
10-year median: 25.6×
Against its 10-year history: 2nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 13.1× to 46.9×
Peer median: 18.5×

Boston Scientific's forward PE is 14.1× as of Oct 23, 2026.

That is below its ten-year median of 25.6×, lower than on 98% of days in the last ten years.

Over that time it ranged from 13.1× in Oct 2026 to 46.9× in Feb 2020.

The median for 7 medical device stocks of a similar size is 18.5×.

Forward PE over time

median 25.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	14.1×	13.1×	31.0×
2025	30.5×	29.4×	37.0×
2024	32.7×	26.5×	33.3×
2023	26.3×	22.5×	27.2×
2022	24.7×	20.4×	26.6×
2021	25.2×	22.8×	28.2×
2020	25.9×	24.2×	46.9×
2019	43.7×	22.5×	43.9×
2018	23.6×	19.6×	27.2×
2017	18.9×	18.5×	23.0×
2016	18.0×	16.3×	21.2×
2015	18.8×	15.6×	21.2×
2014	15.5×	13.7×	20.5×
2013	18.3×	15.2×	22.7×
2012	14.3×	12.1×	16.6×
2011	14.8×	14.3×	26.0×
2010	24.4×	17.8×	30.4×
2009	29.0×	11.7×	29.0×
2008	13.7×	11.4×	38.8×
2007	35.5×	35.5×	68.3×

Against its peers

Companies in Medical - Devices nearest Boston Scientific's size, closest first, today.

Company	Forward PE
BSXBoston Scientific	14.1×
EWEdwards Lifesciences	28.3×
SYKStryker	19.3×
MDTMedtronic	15.9×
GEHCGE HealthCare Technologies	13.8×
DXCMDexCom	27.7×
ABTAbbott Laboratories	17.7×
ZBHZimmer Biomet	n/m
Peer median	18.5×

Where Boston Scientific ranks

#10of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Boston Scientific

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.